14-3-3-zeta mediates GLP-1 receptor agonist action to alter α cell proglucagon processing is a research paper published in Science Advances (2022). On theSindex it has a DataRank of 0. It has been cited 11 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIDDK NIH HHS
Grant: F30 DK126538
NIDDK NIH HHS
Grant: P30 DK020541
NIDDK NIH HHS
Grant: UC4 DK098085
NIDDK NIH HHS
Grant: R56 DK124853
NIH HHS
Grant: T35 OD010941
NIH HHS
Grant: S10 OD017992
National Institutes of Health
Grant: 1UC4DK098085-01
The Human Islet Distribution Coordinating Center (UC4)
National Institutes of Health
Grant: 1ZIADK013039-04
Molecular modeling of soluble proteins
National Institutes of Health
Grant: 5F30DK126538-02
Defining alpha-cell PC1/3 expression regulation for type 2 diabetes
National Institutes of Health
Grant: 1S10OD017992-01
Acquisition of a Hybrid Quadrupole Time of Flight LC-MS/MS System for the Cornell
National Institutes of Health
Grant: 7R56DK124853-02
Defining alpha-cell proglucagon processing for type 2 diabetes treatment
FWCI
0.86
Citation Percentile
0.7%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals